The Global Market for Organ Preservation Solutions is Projected to Reach US$272.9 Million by 2024

Growing Demand for Organ Transplantations to Drive the Global Organ Preservation Solutions Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market size, share and demand forecasts on the global Organ Preservation Solutions market. The global market for Organ Preservation Solutions is projected to reach US$272.9 million by 2024, driven by the growing number of patients awaiting transplants, insufficient organ donations and the need to uphold organ function until transplant. 

Transplantation is a widely acknowledged way to treat an end-stage organ disease. Aging population and increasing incidence of organ failure are driving demand for organ transplantation worldwide. However, with organ donations lagging significantly behind the number of patients waiting for transplants, the site of donation of this scarce resource and the site where a patient is to receive the organ may be geographically separated creating the need to preserve organ health and function for sufficient time until transplanted. This is further compounded by the shorter shelf life of an organ outside the human body. Failure in initiation of graft function post-transplant care has dire implications in the form of morbidity, mortality, high financial expenditure and wastage of the resource. Organ preservation solutions come to the rescue, enabling organs to bear the harsh conditions outside the human body. A wide range of solutions are available today for organ preservation, including University of Wisconsin (UW) Solution, Euro-Collins, Celsior, Kyoto ET Solution, Phosphate Buffered Sucrose Solution and Histidine-Tryptophan-Ketoglutarate (HTK), differing in antioxidants, buffers, energy substrates and impermeants. Preservation solutions aim to delay destruction of cells, prevent cellular edema, uphold organ metabolic potential, and enhance organ function following reestablishment of perfusion. Increasing awareness on the importance of organ donations, efforts from governments and non-government organizations to spread awareness and tie-ups between manufacturers and medical institutions and research organizations are contributing to growth in the market.

Organ preservation solutions have been playing an important role in increasing the number of successful organ transplants by reducing transplant failures. UW solution has been the most established and popular preservation solution for preserving various organs meant for transplant. HTK, on the other hand, has gained popularity in recent years driven by positive results from various studies and lower costs. Kidney transplantation remains the largest application by the virtue of highest number of transplants among organs, worldwide. Technological developments are critical to market evolution and organ preservation solutions and are seeing considerable progress, which are further expected to contribute to market growth. Manufacturers and researchers are exploring process and product improvements as well as expansion of applications of current solutions, potentially resulting in significant knowledge on aptness of existing and new solutions in various transplant settings and in turn boosting market growth prospects. Trends such emergence and growing research in warm perfusion techniques, as against cold perfusion, could potentially affect the market. Despite the existence of positive drivers, certain factors continue to drag growth in the market. These include low level of organ donations, limited reimbursement for organ transplantations in several markets across the globe, and product recalls and issued warnings over contamination issues.     

As stated by the new market research report on Organ Preservation Solutions, Europe represents the largest market worldwide. Asia-Pacific ranks as the fastest growing market worldwide, with a CAGR of 13.8% through the analysis period, driven by increasing incidence of chronic diseases and organ failures, improving healthcare infrastructure and rising healthcare spending alongside rising medical tourism in some of the markets in the region.    

Major players in the market include 21st Century Medicine, BioLife Solutions Inc., Dr. Franz Köhler Chemie GmbH, Essential Pharmaceuticals LLC, Lifeline Scientific Inc., Preservation Solutions Inc. and XVIVO Perfusion AB, among others. 

The research report titled “Organ Preservation Solutions: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections for Organ Preservation Solutions in value terms for all major geographic markets such as United States, Canada, Europe, Asia-Pacific and Rest of World.

To connect with us, visit our LinkedIn page.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.